Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonazepam mouthwash with or without vitamin B1 and alpha lipoic acid for idiopathic burning mouth
IRCT20230413057893N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in glossodynia (BMS) comparing Clonazepam mouthwash with Clonazepam mouthwash + vitamin B1 + alpha lipoic acid (2 arms). Primary endpoint: Amount of mouth burning. Started Jun 2023; status: completed.
02
Drugs
clonazepamthiaminealpha-lipoic acid
03
Conditions
glossodynia (BMS)
Beyond the preview
Go deeper on IRCT20230413057893N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230413057893N1.